Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix. 2002

Ik-Jae Lee, and Kyung-Ran Park, and Kang-Kyoo Lee, and Ji-Sun Song, and Kwang-Gil Lee, and Jong-Young Lee, and Dong-Soo Cha, and Hyun-Il Choi, and Dong-Hee Kim, and Young-Kun Deung
Department of Radiation Oncology, Yonsei University Wonju College of Medicine, Wonju Christian Hospital, Wonju, South Korea.

OBJECTIVE To clarify the role of vascular endothelial growth factor (VEGF) expression as an independent prognostic factor in Stage IB cervical cancer. METHODS A total of 117 patients with Stage IB cervical cancer who had undergone radical hysterectomy and pelvic lymph node dissection with complete histopathologic examination were included. Eighty-eight (75.2%) patients received postoperative radiotherapy and/or chemotherapy. VEGF expression was examined using immunohistochemistry. RESULTS Of 117 patients, 35 (29.9%) showed high-intensity VEGF expression and 69 (59%) had a high score for area of VEGF expression. Strong correlations were found between high VEGF intensity and both deep stromal invasion (p = 0.01) and positive pelvic lymph nodes (p = 0.03). The area of VEGF expression was significantly associated with tumor size (p = 0.02). In a multivariate analysis, high VEGF intensity (p = 0.009) and tumor size (p = 0.01) were significant prognostic factors for overall survival and disease-free survival (p = 0.001 and p = 0.003, respectively). However, the area of VEGF expression was not a prognostic factor for overall survival or disease-free survival. CONCLUSIONS Our findings on the correlation between VEGF expression and prognosis were conflicting. Functional and quantitative tools to assess tumor angiogenesis in addition to the expression of VEGF need to be developed and would be helpful to support the finding that tumor angiogenesis correlates significantly with prognosis in early-stage cervical cancer.

UI MeSH Term Description Entries
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Ik-Jae Lee, and Kyung-Ran Park, and Kang-Kyoo Lee, and Ji-Sun Song, and Kwang-Gil Lee, and Jong-Young Lee, and Dong-Soo Cha, and Hyun-Il Choi, and Dong-Hee Kim, and Young-Kun Deung
May 1989, Clinical radiology,
Ik-Jae Lee, and Kyung-Ran Park, and Kang-Kyoo Lee, and Ji-Sun Song, and Kwang-Gil Lee, and Jong-Young Lee, and Dong-Soo Cha, and Hyun-Il Choi, and Dong-Hee Kim, and Young-Kun Deung
September 1978, Obstetrics and gynecology,
Ik-Jae Lee, and Kyung-Ran Park, and Kang-Kyoo Lee, and Ji-Sun Song, and Kwang-Gil Lee, and Jong-Young Lee, and Dong-Soo Cha, and Hyun-Il Choi, and Dong-Hee Kim, and Young-Kun Deung
March 1996, Cancer,
Ik-Jae Lee, and Kyung-Ran Park, and Kang-Kyoo Lee, and Ji-Sun Song, and Kwang-Gil Lee, and Jong-Young Lee, and Dong-Soo Cha, and Hyun-Il Choi, and Dong-Hee Kim, and Young-Kun Deung
December 1989, International journal of radiation oncology, biology, physics,
Ik-Jae Lee, and Kyung-Ran Park, and Kang-Kyoo Lee, and Ji-Sun Song, and Kwang-Gil Lee, and Jong-Young Lee, and Dong-Soo Cha, and Hyun-Il Choi, and Dong-Hee Kim, and Young-Kun Deung
March 1984, American journal of obstetrics and gynecology,
Ik-Jae Lee, and Kyung-Ran Park, and Kang-Kyoo Lee, and Ji-Sun Song, and Kwang-Gil Lee, and Jong-Young Lee, and Dong-Soo Cha, and Hyun-Il Choi, and Dong-Hee Kim, and Young-Kun Deung
January 1995, Anticancer research,
Ik-Jae Lee, and Kyung-Ran Park, and Kang-Kyoo Lee, and Ji-Sun Song, and Kwang-Gil Lee, and Jong-Young Lee, and Dong-Soo Cha, and Hyun-Il Choi, and Dong-Hee Kim, and Young-Kun Deung
December 1990, Yonsei medical journal,
Ik-Jae Lee, and Kyung-Ran Park, and Kang-Kyoo Lee, and Ji-Sun Song, and Kwang-Gil Lee, and Jong-Young Lee, and Dong-Soo Cha, and Hyun-Il Choi, and Dong-Hee Kim, and Young-Kun Deung
June 2000, Acta medica Okayama,
Ik-Jae Lee, and Kyung-Ran Park, and Kang-Kyoo Lee, and Ji-Sun Song, and Kwang-Gil Lee, and Jong-Young Lee, and Dong-Soo Cha, and Hyun-Il Choi, and Dong-Hee Kim, and Young-Kun Deung
January 2001, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology,
Ik-Jae Lee, and Kyung-Ran Park, and Kang-Kyoo Lee, and Ji-Sun Song, and Kwang-Gil Lee, and Jong-Young Lee, and Dong-Soo Cha, and Hyun-Il Choi, and Dong-Hee Kim, and Young-Kun Deung
July 1999, Obstetrics and gynecology,
Copied contents to your clipboard!